The antibody drug is able to reduce the risk of severe Covid-19 or death by 88 per cent. - The Straits Times/ANN
SINGAPORE, Dec 10 (The Straits Times/ANN): Supplies of AstraZeneca's antibody drug for the treatment of Covid-19 are expected to arrive by the end of the year, after Singapore signed a new purchase agreement with the drugmaker.
Known as Evusheld, the drug cocktail is a combination of two "long" antibodies - which take longer to metabolise in the body and can provide longer-lasting protection for up to a year, compared with monoclonal antibodies.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
